ARTICLE | Company News
MacroGenics, PolyTherics deal
December 13, 2010 8:00 AM UTC
PolyTherics will apply its TheraPEG site-specific PEGylation technology to a preclinical bi-specific antibody from MacroGenics' Dual-Affinity Re-Targeting (DART) technology. MacroGenics will also have...